Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02283320
Title A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BIND Therapeutics
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Investigative Site: #51 Chandler Arizona 85224 United States Details
Investigative Site: #30 Goodyear Arizona 85338 United States Details
Investigative Site: #44 Phoenix Arizona 85016 United States Details
Investigative Site: #41 Sedona Arizona 86336 United States Details
Investigative Site: #58 Duarte California 91010 United States Details
Investigative Site: #47 La Jolla California 92093 United States Details
Investigative Site: #32 Los Angeles California 90048 United States Details
Investigative Site: #50 San Francisco California 94115 United States Details
Investigative Site: #46 Fort Meyers Florida 33916 United States Details
Investigative Site: #53 Newnan Georgia 30265 United States Details
Investigative Site: #56 Savannah Georgia 31405 United States Details
Investigative Site: #35 Zion Illinois 60099 United States Details
Investigative Site: #36 Las Vegas Nevada 89119 United States Details
Investigative Site: #60 Portland Oregon 97239 United States Details
Investigative Site: # 59 Pittsburgh Pennsylvania 15240 United States Details
Investigative Site: #34 Pittsburg Pennsylvania 15232 United States Details
Investigative Site: #39 Amarillo Texas 79106 United States Details
Investigative Site: #42 Dallas Texas 75231 United States Details
Investigative Site: 38 Dallas Texas 75237 United States Details
Investigative Site: #40 Blacksburg Virginia 24060 United States Details
Investigative Site: #45 Vancouver Washington 98684 United States Details
Investigative Site: #37 Yakima Washington 98902 United States Details
Investigative Site: #72 Ufa Bashkortastan 450054 Russian Federation Details
Investigative Site: #75 Istra settle. Moscow Region 143423 Russian Federation Details
Investigative Site: #74 Archangelsk 163045 Russian Federation Details
Investigative Site: #78 Kazan 420029 Russian Federation Details
Investigative Site: #70 Moscow 115478 Russian Federation Details
Investigative Site: #79 Rostov-on-Don 603024 Russian Federation Details
Investigative Site: #76 Saint Petersburg 197022 Russian Federation Details
Investigative Site: #71 Saint Petersburg 197758 Russian Federation Details
Investigative Site: #73 Saint Petersburg 197758 Russian Federation Details
Investigative Site: #77 Saint Petersburg 198255 Russian Federation Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field